Vaginal and urinary microbiomes shift during hormone therapy
Hot flashes often improve quickly during menopause hormone therapy, but intimate wellness and sleep changes take entirely different paths. Mondosanità reported on a study published Nov. 3, 2026, in Nature Medicine exploring whether human microorganisms help explain why treatments work differently for every woman.
Researchers tracked 356 perimenopausal women aged 40 to 55 across 14 Chinese medical centers over six months of oral estradiol and dydrogesterone treatment, according to the Mondosanità report. Scientists analyzed gut, oral, vaginal, and urinary samples to map microbial shifts during the hormone regimen. The most pronounced environmental changes appeared in the vaginal and urinary tracts rather than the gut. Vaginal samples showed an increase in Lactobacillus crispatus alongside a decrease in Gardnerella vaginalis.
Baseline microbial profiles dictate recovery variance
Microbial responses varied across participants, meaning no two women experienced identical shifts. Baseline microbial characteristics directly associated with how fast and effectively individual symptoms improved, Mondosanità reported based on a multicenter report from BGI. Sexual function recovery also showed high variability among the participants.
Gut bacteria and estrogen recirculation require experimental confirmation
Researchers noted a potential link involving gut bacteria and estrogen recirculation, though that specific mechanism requires direct experimental confirmation. The observational study lacked a placebo group and evaluated only one specific therapeutic formulation. Investigators cannot determine how much symptom change stems directly from the therapy versus natural variance.
Expert warnings against premature commercial tests
Experts caution against commercial shortcuts like buying microbiome tests or probiotics based on preliminary associations. Treatment options include vaginal estrogens, non-hormonal moisturizers, and lubricants tailored to personal medical history.
Vaginal estrogens target dryness but not hot flashes
Vaginal estrogens target local dryness and irritation but do not treat hot flashes or sleep disturbances. The National Health Service recommends a follow-up review roughly three months after starting or changing hormone therapies to assess persistent symptoms. The question patients often ask clinicians is whether specific lingering discomforts warrant an adjusted treatment plan.
Related reading